Corbett Accel names Kelly to head N.Y. shop

Corbett Accel has named Carleen Kelly to lead its New York office as president.

Kelly, who joined Corbett Accel in March as head of the firm's Vytorin business with Merck, replaces Richard Nordstrom, who left Corbett Accel earlier this month to become chief executive of Interpublic Group's McCann Healthcare Worldwide. Before joining Corbett Accel, Kelly was executive vice president and chief operating officer at Torre Lazur McCann Worldwide. She reports to Corbett Accel chief executive Scott Cotherman.

The Omnicom Group company recently appointed Elaine Eisen to head its flagship Chicago office. Separately, group creative director Camille DeSantis left to join Edelman as vice president, creative director.

Omnicom merged its Corbett and Accel units -- specializing in healthcare advertising and medical education, respectively -- in February.

You must be a registered member of MMM to post a comment.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.